PD-L1 and Tumor Infiltrating Lymphocytes as Prognostic Markers in Resected NSCLC

INTRODUCTION: Immune checkpoint inhibition has shifted treatment paradigms in non-small cell lung cancer (NSCLC). Conflicting results have been reported regarding the immune infiltrate and programmed death-ligand 1 (PD-L1) as a prognostic marker. We correlated the immune infiltrate and PD-L1 express...

Descripción completa

Detalles Bibliográficos
Autores principales: Ameratunga, Malaka, Asadi, Khashayar, Lin, Xihui, Walkiewicz, Marzena, Murone, Carmel, Knight, Simon, Mitchell, Paul, Boutros, Paul, John, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841565/
https://www.ncbi.nlm.nih.gov/pubmed/27104612
http://dx.doi.org/10.1371/journal.pone.0153954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841565/
https://www.ncbi.nlm.nih.gov/pubmed/27104612
http://dx.doi.org/10.1371/journal.pone.0153954

Ejemplares similares